US 10308698
Therapeutic targeting of SET1B/compass pathway for treating cancers
granted A61KA61K38/2264
Quick answer
US patent 10308698 (Therapeutic targeting of SET1B/compass pathway for treating cancers) held by Northwestern University expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/2264